REGN•benzinga•
RBC Capital Maintains Sector Perform on Regeneron Pharmaceuticals, Lowers Price Target to $647
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 2, 2022 by benzinga